In Vitro Toxicology Testing Market By Product (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Tissue Culture Assays, Western Blots, Cell Based ELISA, Receptor Binding Assays), By Technology (Cellular Imaging Technology, High Throughput Technology, Toxic Genomics, Cell Culture Technology), By Endpoint (Skin Sensitization and Irritation, Cytotoxicity, Neurotoxicity, Geno Toxicity, Ocular Toxicity, Photo Toxicity, Carcinogenicity, Organ Toxicity, Dermal Toxicity), By Method (Ex Vivo Models, Cellular Assays, Biochemical Assays), By End User (Pharmaceutical Industry, Biopharmaceutical Industry, Cosmetics Industry, Household Products Industry, Chemicals Industry, Food Industry) and By Geography.


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global in-vitro toxicology testing market size valued at USD 8.92 billion in 2020 and expected to reach USD 18.03 billion by 2027, growing at a CAGR of 11.0% during forecast period 2021 to 2027. The technique of determining the potential for dangerous compounds is known as in-vitro toxicity testing. It's also utilised to check for the presence of specific hazardous properties in useful substances like agricultural chemicals, therapeutic medications, and food additives. Toxicity testing is required in the development of new compounds since detecting possible toxicity earlier in the drug development process can save time and money, as well as reduce the risk of late-stage failure. In vitro toxicology testing is used to determine whether hazardous substances or poisons are present in an organism's cells. In vitro toxicology testing is an analysis of effects of the toxic substances on cultured mammalian cells or bacteria. These techniques are primarily employed for identification of potential hazardous chemicals in order to confirm the certain toxic properties at early development stages of therapeutic drugs. In vitro toxicology testing market is highly fragmented due to presence of many market players, expected to offer lucrative growth during the forecast period. Market players are concentrated on development of new software solutions, introduction of innovative technologies, enhancing in silico simulation methods in toxicological profiling. Companies are adopting various growth strategies such as new product launches, acquisitions and mergers in order to enhance the product portfolio and market presence.

In Vitro Toxicology Testing Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Asia Pacific
In Vitro Toxicology Testing Market Dynamics

Increase in advanced technologies, rise in R&D activities in cell cultures, rise in demand for in vitro toxicology tests are expected to fuel revenue growth of in vitro toxicology testing market. Furthermore, growing awareness regarding in vitro toxicology tests, growing healthcare concern among individuals, growing economic status of developing regions are expected to offer robust growth opportunities for global in vitro toxicology testing market. On the other hand, stringent regulatory framework, scarcity of in vitro models to detect auto immunity and immune stimulation, technological disadvantages are restraints of the in vitro toxicology testing market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

In Vitro Toxicology Testing Market Segmentation

By Product Type
  • Bacterial Toxicity Assays
  • Enzyme Toxicity Assays
  • Tissue Culture Assays
  • Western Blots
  • Cell Based ELISA
  • Receptor Binding Assays
By Technology
  • Cellular Imaging Technology
  • High Throughput Technology
  • Toxic Genomics
  • Cell Culture Technology
Based On Method
  • Ex Vivo Models
  • Cellular Assays
  • Biochemical Assays
By End User
  • Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Cosmetics Industry
  • Chemicals Industry
  • Food Industry

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']
  • Cyprotex (Germany)
  • GE Healthcare (U.S.)
  • Covance (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Eurofins Scientific SE (Luxembourg)
  • Promega Corporation (U.S.)
  • SGS SA (Switzerland)
  • Merck KGaA (Germany)
  • Lonza Group Ltd. (Switzerland)
  • Charles River Laboratories, Inc. (U.S.)